Cart
sales@molnova.com
Levofloxacin N-oxide
CAS No. 117678-38-3
Levofloxacin N-oxide ( —— )
Catalog No. M28153 CAS No. 117678-38-3
Levofloxacin N-oxide is an impurity isolated from levofloxacin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 111 | Get Quote |
|
| 10MG | 194 | Get Quote |
|
| 25MG | 326 | Get Quote |
|
| 50MG | 491 | Get Quote |
|
| 100MG | 708 | Get Quote |
|
| 500MG | 1467 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLevofloxacin N-oxide
-
NoteResearch use only, not for human use.
-
Brief DescriptionLevofloxacin N-oxide is an impurity isolated from levofloxacin.
-
DescriptionLevofloxacin N-oxide is an impurity isolated from levofloxacin.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor5-HT4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number117678-38-3
-
Formula Weight377.4
-
Molecular FormulaC18H20FN3O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFC1=C(N2CCN(CC2)(C)=O)C(OC[C@H](C)N3C=C(C(O)=O)C4=O)=C3C4=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tadayoshi Mikami, et al. 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs. J Pharmacol Exp Ther. 2008 Apr;325(1):190-9.
molnova catalog
related products
-
4-Isopropylcatechol
4-Isopropylcatechol is a potent depigmenting agent and is of use in the topical therapy of selected patients with hypermelanosis.
-
ACH-000143
ACH-000143 have been identified as a novel agonist of the melatonin receptors MT1 and MT2.
-
3-Hydroxybenzoic aci...
Produced in the gut microflora as one of the three main metabolites formed from the catechin diet. Its use in the production of glycol benzoates for the application of plasticizer in adhesive formulations is increasing.
